FDA Postpones Plan B OTC Switch Decision Until May
This article was originally published in The Pink Sheet Daily
Ninety-day extension of the user fee deadline will allow the agency to review additional data on adolescent use of the emergency contraceptive, Barr says.
You may also be interested in...
Group led by Rep. Waxman is requesting that GAO examine communications between the White House and HHS regarding FDA's decision not to approve the Plan B emergency contraceptive switch application.
FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.